BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29974555)

  • 1. Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma.
    Chin TH; Lin G; Wu RC; Lai CH
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1836-1842. PubMed ID: 29974555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
    Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M
    J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
    Shoji K; Oda K; Nakagawa S; Kawana K; Yasugi T; Ikeda Y; Takazawa Y; Kozuma S; Taketani Y
    Med Oncol; 2011 Sep; 28(3):771-4. PubMed ID: 20354812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial stromal sarcoma: a rare entity.
    Jabeen S; Anwar S; Fatima N
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):216-7. PubMed ID: 25772965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma.
    Xie W; Cao D; Yang J; Jiang X; Shen K; Pan L; Huang H; Lang J; You Y; Chen J
    Oncotarget; 2017 Feb; 8(6):10602-10608. PubMed ID: 27736798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports.
    Garavaglia E; Pella F; Montoli S; Voci C; Taccagni G; Mangili G
    Int J Gynecol Cancer; 2010 Oct; 20(7):1197-200. PubMed ID: 21495227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W; Hua K; Malpica A; Zhou X; Baak JP
    Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].
    Wang YQ; Zhou R; Xu LJ; Xia M; Lu Q; Liu GL; Shen DH; Wang G; He M; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):327-332. PubMed ID: 32464721
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
    Stewart LE; Beck TL; Giannakopoulos NV; Rendi MH; Isacson C; Goff BA
    Gynecol Oncol; 2018 May; 149(2):297-300. PubMed ID: 29534832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
    Gong Q; Chen X; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
    Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L
    Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
    Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
    Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases].
    Shi JL; Cheng NH; Guo LN; Lian LJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):517-22. PubMed ID: 22169638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
    Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence.
    Koskas M; Morice P; Yazbeck C; Duvillard P; Walker F; Madelenat P
    Anticancer Res; 2009 Oct; 29(10):4147-50. PubMed ID: 19846964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis.
    Nasioudis D; Ko EM; Kolovos G; Vagios S; Kalliouris D; Giuntoli RL
    Int J Gynecol Cancer; 2019 Jan; 29(1):126-132. PubMed ID: 30640694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.